Envestnet Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.06B | Buy |
4,853,567
+25,341
| +0.5% | +$5.62M | 0.28% | 64 |
|
|
2025
Q4 | $1.1B | Sell |
4,828,226
-470,526
| -9% | -$107M | 0.33% | 60 |
|
|
2025
Q3 | $1.23B | Sell |
5,298,752
-78,555
| -1% | -$16M | 0.35% | 54 |
|
|
2025
Q2 | $998M | Buy |
5,377,307
+317,739
| +6% | +$59.1M | 0.29% | 61 |
|
|
2025
Q1 | $1.06B | Buy |
5,059,568
+95,756
| +2% | +$18.6M | 0.34% | 56 |
|
|
2024
Q4 | $882M | Sell |
4,963,812
-14,818
| -0.3% | -$2.72M | 0.28% | 62 |
|
|
2024
Q3 | $983M | Sell |
4,978,630
-72,968
| -1% | -$13.6M | 0.32% | 58 |
|
|
2024
Q2 | $866M | Buy |
5,051,598
+381,871
| +8% | +$63.3M | 0.3% | 60 |
|
|
2024
Q1 | $850M | Buy |
4,669,727
+99,746
| +2% | +$17.2M | 0.32% | 56 |
|
|
2023
Q4 | $708M | Buy |
4,569,981
+172,672
| +4% | +$25.2M | 0.29% | 63 |
|
|
2023
Q3 | $655M | Buy |
4,397,309
+1,130,638
| +35% | +$166M | 0.3% | 60 |
|
|
2023
Q2 | $440M | Sell |
3,266,671
-115,099
| -3% | -$16.9M | 0.2% | 85 |
|
|
2023
Q1 | $532M | Sell |
3,381,770
-37,630
| -1% | -$5.75M | 0.26% | 65 |
|
|
2022
Q4 | $553M | Buy |
3,419,400
+7,958
| +0.2% | +$1.22M | 0.29% | 63 |
|
|
2022
Q3 | $458M | Buy |
3,411,442
+99,724
| +3% | +$14.3M | 0.26% | 69 |
|
|
2022
Q2 | $507M | Sell |
3,311,718
-14,645
| -0.4% | -$2.24M | 0.28% | 67 |
|
|
2022
Q1 | $539M | Buy |
3,326,363
+140,424
| +4% | +$20.4M | 0.27% | 70 |
|
|
2021
Q4 | $431M | Buy |
3,185,939
+55,168
| +2% | +$6.52M | 0.21% | 87 |
|
|
2021
Q3 | $338M | Buy |
3,130,771
+172,841
| +6% | +$19.7M | 0.19% | 96 |
|
|
2021
Q2 | $333M | Buy |
2,957,930
+78,780
| +3% | +$8.87M | 0.19% | 100 |
|
|
2021
Q1 | $312M | Buy |
2,879,150
+579,176
| +25% | +$62M | 0.2% | 92 |
|
|
2020
Q4 | $246M | Buy |
2,299,974
+32,956
| +1% | +$3.17M | 0.19% | 86 |
|
|
2020
Q3 | $199M | Sell |
2,267,018
-3,087
| -0.1% | -$291K | 0.18% | 99 |
|
|
2020
Q2 | $223M | Buy |
2,270,105
+148,701
| +7% | +$13.1M | 0.22% | 85 |
|
|
2020
Q1 | $162M | Buy |
2,121,404
+348,115
| +20% | +$29.7M | 0.19% | 89 |
|
|
2019
Q4 | $157M | Buy |
1,773,289
+485,004
| +38% | +$40.3M | 0.17% | 105 |
|
|
2019
Q3 | $97.5M | Buy |
1,288,285
+126,826
| +11% | +$8.7M | 0.11% | 146 |
|
|
2019
Q2 | $84.5M | Buy |
1,161,459
+7,127
| +0.6% | +$560K | 0.11% | 145 |
|
|
2019
Q1 | $93M | Buy |
1,154,332
+56,969
| +5% | +$4.66M | 0.13% | 124 |
|
|
2018
Q4 | $101M | Buy |
1,097,363
+1,069,620
| +3,855% | +$94.1M | 0.16% | 103 |
|
|
2018
Q3 | $2.62M | Sell |
27,743
-161,891
| -85% | -$15.4M | ﹤0.01% | 555 |
|
|
2018
Q2 | $17.6M | Sell |
189,634
-686
| -0.4% | -$67K | 0.04% | 208 |
|
|
2018
Q1 | $18.2M | Sell |
190,320
-100,583
| -35% | -$11M | 0.05% | 136 |
|
|
2017
Q4 | $28.1M | Sell |
290,903
-14,186
| -5% | -$1.34M | 0.06% | 163 |
|
|
2017
Q3 | $27.1M | Sell |
305,089
-103,064
| -25% | -$7.85M | 0.06% | 159 |
|
|
2017
Q2 | $29.6M | Sell |
408,153
-24,854
| -6% | -$1.67M | 0.08% | 150 |
|
|
2017
Q1 | $28.2M | Buy |
433,007
+9,061
| +2% | +$570K | 0.09% | 150 |
|
|
2016
Q4 | $26.6M | Buy |
423,946
+51,082
| +14% | +$3.12M | 0.1% | 152 |
|
|
2016
Q3 | $23.5M | Sell |
372,864
-72,501
| -16% | -$4.69M | 0.09% | 169 |
|
|
2016
Q2 | $27.6M | Buy |
445,365
+17,151
| +4% | +$1.05M | 0.11% | 158 |
|
|
2016
Q1 | $24.5M | Buy |
428,214
+80,280
| +23% | +$4.47M | 0.11% | 166 |
|
|
2015
Q4 | $20.6M | Sell |
347,934
-62,357
| -15% | -$3.59M | 0.09% | 198 |
|
|
2015
Q3 | $22.3M | Buy |
410,291
+4,843
| +1% | +$315K | 0.11% | 161 |
|
|
2015
Q2 | $27.2M | Buy |
405,448
+13,502
| +3% | +$881K | 0.13% | 155 |
|
|
2015
Q1 | $22.9M | Buy |
391,946
+362,875
| +1,248% | +$21.9M | 0.12% | 178 |
|
|
2014
Q4 | $1.9M | Sell |
29,071
-10,988
| -27% | -$693K | 0.02% | 392 |
|
|
2014
Q3 | $2.31M | Buy |
40,059
+504
| +1% | +$28K | 0.02% | 367 |
|
|
2014
Q2 | $2.23M | Buy |
39,555
+2,647
| +7% | +$139K | 0.02% | 355 |
|
|
2014
Q1 | $1.9M | Sell |
36,908
-1,634
| -4% | -$82.6K | 0.02% | 326 |
|
|
2013
Q4 | $2.04M | Buy |
38,542
+5,126
| +15% | +$252K | 0.02% | 304 |
|
|
2013
Q3 | $1.5M | Buy |
33,416
+4,190
| +14% | +$186K | 0.02% | 328 |
|
|
2013
Q2 | $1.21M | Buy |
+29,226
| New | +$1.28M | 0.02% | 373 |
|
Other funds holding ABBV
VCM
VPM
Envestnet Asset Management's ABBV Position: Q1 2026 in Review
Envestnet Asset Management increased its AbbVie (ABBV) stake by 0.52% in Q1 2026, buying an estimated $5.62M and bringing the position to 4,853,567 shares worth $1.06B. The position accounts for 0.28% of the portfolio, ranked #64.
Envestnet Asset Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.23B in Q3 2025. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Envestnet Asset Management held 4,853,567 shares of AbbVie worth $1.06B as of Q1 2026.
- Envestnet Asset Management bought 25,341 AbbVie shares in Q1 2026, an estimated $5.62M.
- AbbVie made up 0.28% of Envestnet Asset Management's portfolio in Q1 2026, its #64 holding.
- Envestnet Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Envestnet Asset Management's AbbVie position peaked at $1.23B in Q3 2025.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.